Shanghai Pharmaceuticals and Syntegon have signed an agreement to build a laboratory for continuous manufacturing technology in China. The cooperation will promote the application of this new technology, shorten development cycles of new drugs, reduce...
Shanghai Pharmaceuticals is looking to buy companies in the U.S. and Europe. This acquisition strategy is part of its two-pronged approach to growth, along with internal research and development.